633 research outputs found

    Differential effects of lobe A and lobe B of the Conserved Oligomeric Golgi complex on the stability of β1,4-galactosyltransferase 1 and α2,6-sialyltransferase 1

    Get PDF
    Initially described by Jaeken et al. in 1980, congenital disorders of glycosylation (CDG) is a rapidly expanding group of human multisystemic disorders. To date, many CDG patients have been identified with deficiencies in the conserved oligomeric Golgi (COG) complex which is a complex involved in the vesicular intra-Golgi retrograde trafficking. Composed of eight subunits that are organized in two lobes, COG subunit deficiencies have been associated with Golgi glycosylation abnormalities. Analysis of the total serum N-glycans of COG-deficient CDG patients demonstrated an overall decrease in terminal sialylation and galactosylation. According to the mutated COG subunits, differences in late Golgi glycosylation were observed and led us to address the question of an independent role and requirement for each of the two lobes of the COG complex in the stability and localization of late terminal Golgi glycosylation enzymes. For this, we used a small-interfering RNAs strategy in HeLa cells stably expressing green fluorescent protein (GFP)-tagged β1,4-galactosyltransferase 1 (B4GALT1) and α2,6-sialyltransferase 1 (ST6GAL1), two major Golgi glycosyltransferases involved in late Golgi N-glycosylation. Using fluorescent lectins and flow cytometry analysis, we clearly demonstrated that depletion of both lobes was associated with deficiencies in terminal Golgi N-glycosylation. Lobe A depletion resulted in dramatic changes in the Golgi structure, whereas lobe B depletion severely altered the stability of B4GALT1 and ST6GAL1. Only MG132 was able to rescue their steady-state levels, suggesting that B4GALT1- and ST6GAL1-induced degradation are likely the consequence of an accumulation in the endoplasmic reticulum (ER), followed by a retrotranslocation into the cytosol and proteasomal degradation. All together, our results suggest differential effects of lobe A and lobe B for the localization/stability of B4GALT1 and ST6GAL1. Lobe B would be crucial in preventing these two Golgi glycosyltransferases from inappropriate retrograde trafficking to the ER, whereas lobe A appears to be essential for maintaining the overall Golgi structur

    Differential effects of lobe A and lobe B of the conserved oligomeric golgi complex on the stability of β1,4-galactosyltransferase 1 and α2,6-sialyltransferase 1

    Get PDF
    Erworben im Rahmen der Schweizer Nationallizenzen (http://www.nationallizenzen.ch)Initially described by Jaeken et al. in 1980, congenital disorders of glycosylation (CDG) is a rapidly expanding group of human multisystemic disorders. To date, many CDG patients have been identified with deficiencies in the conserved oligomeric Golgi (COG) complex which is a complex involved in the vesicular intra-Golgi retrograde trafficking. Composed of eight subunits that are organized in two lobes, COG subunit deficiencies have been associated with Golgi glycosylation abnormalities. Analysis of the total serum N-glycans of COG-deficient CDG patients demonstrated an overall decrease in terminal sialylation and galactosylation. According to the mutated COG subunits, differences in late Golgi glycosylation were observed and led us to address the question of an independent role and requirement for each of the two lobes of the COG complex in the stability and localization of late terminal Golgi glycosylation enzymes. For this, we used a small-interfering RNAs strategy in HeLa cells stably expressing green fluorescent protein (GFP)-tagged β1,4-galactosyltransferase 1 (B4GALT1) and α2,6-sialyltransferase 1 (ST6GAL1), two major Golgi glycosyltransferases involved in late Golgi N-glycosylation. Using fluorescent lectins and flow cytometry analysis, we clearly demonstrated that depletion of both lobes was associated with deficiencies in terminal Golgi N-glycosylation. Lobe A depletion resulted in dramatic changes in the Golgi structure, whereas lobe B depletion severely altered the stability of B4GALT1 and ST6GAL1. Only MG132 was able to rescue their steady-state levels, suggesting that B4GALT1- and ST6GAL1-induced degradation are likely the consequence of an accumulation in the endoplasmic reticulum (ER), followed by a retrotranslocation into the cytosol and proteasomal degradation. All together, our results suggest differential effects of lobe A and lobe B for the localization/stability of B4GALT1 and ST6GAL1. Lobe B would be crucial in preventing these two Golgi glycosyltransferases from inappropriate retrograde trafficking to the ER, whereas lobe A appears to be essential for maintaining the overall Golgi structure

    Evaluation of the Performance of Coordinate Measuring Machines in the Industry, Using Calibrated Artefacts

    Get PDF
    AbstractThe coordinate measuring machines (CMM's) has given a new impulse in the field of geometrical and dimensional metrology. The CMM's in industrial environments have become an important resource for the quality systems, monitoring manufacturing processes, reduction errors during the manufacturing process, inspection of product specifications and in continuous quality improvement. However, there is a need to evaluate, through practical, fast, effective and low cost methods, the CMM metrological specifications. Using calibrated artefacts, able to reproduce the geometric elements frequently measured, it seeks to ensure stability of the functional and metrological characteristics between calibrations and simultaneously knowing the errors. With better monitoring of the control parameters it is possible evaluate and optimize the calibration set deadlines, timely detection of faults and failures, detect structural changes and changes in environmental conditions of the laboratories, thus seeking to conduct a more detailed assessment of the stability of metrological characteristics of a CMM in industrial environments

    Minimal Delaunay Triangulations of Hyperbolic Surfaces

    Get PDF
    Motivated by recent work on Delaunay triangulations of hyperbolic surfaces, we consider the minimal number of vertices of such triangulations. First, we show that every hyperbolic surface of genus g has a simplicial Delaunay triangulation with O(g) vertices, where edges are given by distance paths. Then, we construct a class of hyperbolic surfaces for which the order of this bound is optimal. Finally, to give a general lower bound, we show that the ?(?g) lower bound for the number of vertices of a simplicial triangulation of a topological surface of genus g is tight for hyperbolic surfaces as well

    Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik

    Get PDF
    Defects of N-linked glycosylation represent diseases with multiple organ involvements that are classified as congenital disorders of glycosylation (CDG). In recent years, several CDG types have been attributed to defects of dolichol-linked oligosaccharide assembly in the endoplasmic reticulum. The profiling of [3H]mannose-labeled lipid-linked oligosaccharides was instrumental in identifying most of these glycosylation disorders. However, this method is poorly suited for the identification of short lipid-linked oligosaccharide biosynthesis defects. To adequately resolve deficiencies affecting the first steps of lipid-linked oligosaccharide formation, we have used a non-radioactive procedure employing the fluorescence detection of 2-aminobenzamide-coupled oligosaccharides after HPLC separation. By applying this method, we have detected the accumulation of dolichylpyrophosphate-GlcNAc2 in a previously untyped CDG patient. The accumulation pattern suggested a deficiency of the ALG1 β1,4 mannosyltransferase, which adds the first mannose residue to lipid-linked oligosaccharides. This was supported by the finding that this CDG patient was compound heterozygous for three mutations in the ALG1 gene, leading to the amino acid substitutions S150R and D429E on one allele and S258L on the other. The detrimental effect of these mutations on ALG1 protein function was demonstrated in a complementation assay using alg1 Saccharomyces cerevisiae yeast mutants. The ALG1 mannosyltransferase defect described here represents a novel type of CDG, which should be referred to as CDG-I

    Delaunay triangulations of generalized Bolza surfaces

    Get PDF
    The Bolza surface can be seen as the quotient of the hyperbolic plane, represented by the Poincar\'e disk model, under the action of the group generated by the hyperbolic isometries identifying opposite sides of a regular octagon centered at the origin. We consider generalized Bolza surfaces Mg\mathbb{M}_g, where the octagon is replaced by a regular 4g4g-gon, leading to a genus gg surface. We propose an extension of Bowyer's algorithm to these surfaces. In particular, we compute the value of the systole of Mg\mathbb{M}_g. We also propose algorithms computing small sets of points on Mg\mathbb{M}_g that are used to initialize Bowyer's algorithm.Comment: 50 pages, 28 figure

    Minimal Delaunay Triangulations of Hyperbolic Surfaces

    Get PDF
    peer reviewedMotivated by recent work on Delaunay triangulations of hyperbolic surfaces, we consider the minimal number of vertices of such triangulations. First, we show that every hyperbolic surface of genus g has a simplicial Delaunay triangulation with O(g) vertices, where edges are given by distance paths. Then, we construct a class of hyperbolic surfaces for which the order of this bound is optimal. Finally, to give a general lower bound, we show that the Ω(g) lower bound for the number of vertices of a simplicial triangulation of a topological surface of genus g is tight for hyperbolic surfaces as well

    European workshop on genetic testing offer in Europe

    Get PDF
    European Workshop on Genetic Testing Offer in Europe, 19-20/11/2012 The workshop was designed with the aim of bringing together experts and stakeholders in the field of genetic testing to discuss the (future) organization of genetic testing in Europe. Obviously since it will not be possible to adequately deal with all aspects of genetic testing within the framework of one workshop, a limited number of issues have been selected. The selection was based on the importance and urgency of the matter and the need and opportunity for action at the European level, and the likelihood for successful intervention. Primary deliverables of this workshop are planned as to be able to define a vision on the use, value and integration of genomic medicine into clinical practice and to prepare a briefing note to highlight the specific points that deserve the Commission’s interest. Quality of genetic testing and organization of genetic testing services were the two main themes of the scope of the workshop. To warrant the quality of the genetic diagnostic laboratories the way forward is to make accreditation the norm, i.e. the diagnostic laboratories in Europe should be accredited. To further guarantee equity, the regulation should include the requirement for all tests to be within the scope accreditation. The embedding of genetic testing in a healthcare setting can ensure a context where due emphasis is being provided on the individualized medical supervision of patients, the presence of pre-test and post-test counseling, psychological follow-up if appropriate and quality assurance of the tests performed. In light of growing number of companies selling and advertising genetic tests, it is crucial that information is available for healthcare professionals and the general public that gives background on genetic testing and describes the provision of genetic testing services.JRC.I.3-Molecular Biology and Genomic
    corecore